4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
September 3, 2010 12:14 pm US/Eastern
Search
Dynamic quotes   
On
 | Off

4-Traders Homepage  >  Shares  >  NYSE  >  WATSON PHARM   WPI   US9426831031

WATSON PHARM (WPI)

Real time Streaming quotes -
Delayed Quote. Delayed NYSE - 09/03 11:57:55 am
44.51 USD   -0.76%
09/01WATSON PHARM: Watson to Present at the Morgan Stanley Global Healthcare Unplugg..
08/13WATSON PHARM: Watson Plans Q4 2010 ella® (ulipristal acetate) Emergency Contrac..
08/05WATSON PHARM: Watson Q2 Net Revenue Climbs 29 Percent to $875 Million
SummaryQuotesChart AnalysisNewsCalendarCompanyFundamentalsConsensus
 Actuals & Estimates (e)
Income Statement Evolution
WATSON PHARM : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period Décembre 200720082009201020112012
Revenue2 4972 5352 7933 4943 9144 302
EBITDA531,2563,3671,8826,4922,71 018
EBIT277,6392,3482,8650,1735,2836,4
Pre-Tax Profit------
Net income141,0238,4222,0335,9388,8515,0
EPS ( $)1,272,091,962,623,013,53
Dividend per Share ( $)------
Yield------
Annoucement Date02/20/2008
12:00 pm
02/19/2009
12:00 pm
02/23/2010
12:30 pm
---
Finances
WATSON PHARM : Finances
Actuals in M $ Estimates in M $
Fiscal Period Décembre 200720082009201020112012
Debt689,3357,11 243859,2326,3-
Finance-----59,88
Equity1 5571 9722 0162 8973 3054 182
Capital Expenditure75,87100,571,9080,9093,0795,96
Leverage
(Debt/Ebitda)
1,30x0,63x1,85x1,04x0,35x-
Gearing
(Debt/Equity)
44,28%18,11%61,64%29,66%9,87%-
Annoucement Date02/20/2008
12:00 pm
02/19/2009
12:00 pm
02/23/2010
12:30 pm
---
Assessed data source :
© 2010 Thomson Reuters
Valuation
Years 2010e 2011e
Capitalization 5 601 M$ -
Company Value 6 460 M$ 5 927 M$
Capitalization / Revenue 1,60x 1,43x
Company Value / Revenue 1,85x 1,51x
Company Value / EBITDA 7,82x 6,42x
PER 17,09 14,88
ROE 11,60% 11,76%
ROA 7,75% 8,90%
Net Asset Value per Share - -
Book Value per Share 27,02 $ 31,19 $
Cash Flow per Share 3,59 $ 4,34 $
Price Earning Ratio
WATSON PHARM : Price Earning Ratio
EPS & Dividend
WATSON PHARM : EPS Dividend
Price share WATSON PHARM (USA), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /